1789 related articles for article (PubMed ID: 15912514)
61. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
[TBL] [Abstract][Full Text] [Related]
62. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
[TBL] [Abstract][Full Text] [Related]
63. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
64. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
Dunne C; Burke JP; Morrow M; Kell MR
J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
[TBL] [Abstract][Full Text] [Related]
65. Long-term outcome of breast-conserving therapy for breast cancer.
Shimauchi A; Nemoto K; Ogawa Y; Kakuto Y; Sakayauchi T; Takai Y; Ishida T; Ohuchi N; Hirakawa H; Kimura M; Yamada T; Takahashi S; Yamada S
Radiat Med; 2005 Nov; 23(7):485-90. PubMed ID: 16485539
[TBL] [Abstract][Full Text] [Related]
66. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
[TBL] [Abstract][Full Text] [Related]
67. Management of operable invasive breast cancer in women over the age of 70: long-term results of a large-scale single-institution experience.
Laki F; Kirova YM; Savignoni A; Campana F; Levu B; Estève M; Sigal-Zafrani B; Dorval T; Asselain B; Salmon RJ
Ann Surg Oncol; 2010 Jun; 17(6):1530-8. PubMed ID: 20177798
[TBL] [Abstract][Full Text] [Related]
68. Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
Brooks JP; Danforth DN; Albert P; Sciuto LC; Smith SL; Camphausen KA; Poggi MM
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):785-9. PubMed ID: 15936560
[TBL] [Abstract][Full Text] [Related]
69. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
70. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
71. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
72. Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
Kim HJ; Han W; Yi OV; Shin HC; Ahn SK; Koh BS; Moon HG; You JH; Son BH; Ahn SH; Noh DY
Breast Cancer Res Treat; 2011 Nov; 130(2):499-505. PubMed ID: 21853352
[TBL] [Abstract][Full Text] [Related]
73. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Peintinger F; Symmans WF; Gonzalez-Angulo AM; Boughey JC; Buzdar AU; Yu TK; Hunt KK; Singletary SE; Babiera GV; Lucci A; Meric-Bernstam F; Kuerer HM
Cancer; 2006 Sep; 107(6):1248-54. PubMed ID: 16862596
[TBL] [Abstract][Full Text] [Related]
74. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
75. Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?
Cebrecos I; Córdoba O; Deu J; Xercavins J; Rubio IT
Eur J Surg Oncol; 2010 Jun; 36(6):528-34. PubMed ID: 20444571
[TBL] [Abstract][Full Text] [Related]
76. Breast cancer recurrences in elderly patients after lumpectomy.
Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND
Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612
[TBL] [Abstract][Full Text] [Related]
77. Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.
Min SY; Lee SJ; Shin KH; Park IH; Jung SY; Lee KS; Ro J; Lee S; Kim SW; Kim TH; Kang HS; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e697-705. PubMed ID: 21129858
[TBL] [Abstract][Full Text] [Related]
78. Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Garcia-Etienne CA; Barile M; Gentilini OD; Botteri E; Rotmensz N; Sagona A; Farante G; Galimberti V; Luini A; Veronesi P; Bonanni B
Ann Surg Oncol; 2009 Dec; 16(12):3380-7. PubMed ID: 19649554
[TBL] [Abstract][Full Text] [Related]
79. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
80. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
